Revenue
2023
2024
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | — | $3.9M | $5.7M | — | — |
| Gross profit | — | $635,000 | $1.1M | — | — |
| Research & development | $252,000 | $4.4M | $5.9M | — | — |
| Operating expenses | $3.4M | $23.7M | $19.2M | — | — |
| Operating income | −$3.4M | −$23.0M | −$18.1M | −$1.5M | −$10,861 |
| EBITDAderived | — | −$22.9M | −$17.9M | — | — |
| Net income | $9.3M | −$38.1M | −$29.7M | $1.9M | −$10,861 |
| Basic EPSper diluted share | $0.09 | -$1.30 | -$5.82 | — | — |
| Diluted EPSper diluted share | $0.04 | -$1.30 | -$5.82 | — | — |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 12, 2025Form 4 | Kapur SumitChief Financial Officer | BuyWarrant · derivative | — | — | — | — |
| Jun 12, 2025Form 4 | Kapur SumitChief Financial Officer | BuyConvertible Promissory Note · derivative | 1.25M | $100.0K | $100.0K | 1.25M |
| Jun 12, 2025Form 4 | Golestani ClarkDirector | BuyWarrant · derivative | — | — | — | — |
| Jun 12, 2025Form 4 | Golestani ClarkDirector | BuyConvertible Promissory Note · derivative | 1.25M | $100.0K | $100.0K | 1.25M |